Katherine A. McCulloch, PhD

Kate is a patent agent focused on patent application preparation and prosecution in areas such as biotechnology, including biologic therapeutics, oncology, gene therapy, microbiome-based technologies, and genomics. Kate’s scientific background includes graduate studies in genetics, molecular biology, and development at the University of Minnesota and post-doctoral studies in Neurobiology at the University of California, San Diego.

• Co-author, Eukaryotic initiation factor EIF-3.G augments mRNA translation efficiency to regulate neuronal activity. Elife. Published 2021.
• Co-author, Neuronal transcriptome analyses reveal novel neuropeptide modulators of excitation/inhibition imbalance in C. elegans. PLoS One. Published 2020.
• Co-author, Novel mutations in synaptic transmission genes suppress neuronal hyperexcitation in Caenorhabditis elegans. G3. Published 2017.
• Co-author, Analysis of a lin-42/Period Null Allele implicates all three isoforms in regulation of Caenorhabditis elegans molting and developmental timing. G3. Published 2016.
• Co-author, Caenorhabditis elegans period homolog lin-42 regulates the timing of heterochronic miRNA expression. Proceedings of the National Academy of Sciences. Published 2014.